[在痴呆症中分子遗传学和蛋白质分子]
1Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo.
No shinkei geka. Neurological surgery
|October 6, 2025
概括
阿尔茨海默病涉及大脑蛋白质块,如粉样β和团. 新模型和冷EM揭示了结构细节,有助于研究痴呆和向治疗.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默氏症 (AD) 和前性痴呆症 (FTD) 的特征是错误折叠的蛋白质聚合物 (粉样β和).
- 基因突变 (APP,PSEN1,PSEN2,MAPT) 与家族性AD和FTD有关,影响蛋白质聚合.
- 神经炎症和遗传风险因素 (APOE,TREM2) 在AD病变发生过程中发挥作用.
研究的目的:
- 使用冷电子显微镜 (cryo-EM) 探索神经退行性疾病中粉样β (Aβ) 和病理的结构基础.
- 评估当前动物模型在复制类似人类蛋白质结构和疾病进展方面的准确性.
- 突出新型突击模型的潜力,以推进AD和FTD机制和治疗的研究.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 来确定Aβ和tau纤维的高分辨率结构.
- 分析了与AD和FTD相关的遗传因素 (APP,PSEN1,PSEN2,MAPT,APOE,TREM2).
- 将转基因AD模型中的病理特征与人类疾病和新型敲门模型进行比较.
主要成果:
- 冷EM揭示了Aβ和tau纤维的疾病特异性构造,强调了结构多态性.
- 通过质细胞激活,Aβ病理会导致突触功能障碍和神经炎症.
- 现有的转基因模型往往无法复制类似人类的丝状结构和在人类中看到的序列性Aβ-to-tau病理.
结论:
- 来自冷EM的结构见解对于理解AD和FTD的分子机制至关重要.
- 通过冷EM验证的新型敲门模型为研究疾病进展提供了改进的平台.
- 准确的疾病模型对于开发神经退行性疾病的有效,有针对性的治疗方法至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
03:03Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
01:30Dementia
517
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
517
01:28Human Genetics
1.4K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
01:22Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822